Menu
GeneBe

16-172936-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PP3_Strong

The NM_000517.6(HBA2):c.24G>T(p.Lys8Asn) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K8E) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 1)

Consequence

HBA2
NM_000517.6 missense

Scores

5
7
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 4.91
Variant links:
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.99

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HBA2NM_000517.6 linkuse as main transcriptc.24G>T p.Lys8Asn missense_variant 1/3 ENST00000251595.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HBA2ENST00000251595.11 linkuse as main transcriptc.24G>T p.Lys8Asn missense_variant 1/31 NM_000517.6 P1
HBA2ENST00000482565.1 linkuse as main transcriptn.43G>T non_coding_transcript_exon_variant 1/21
HBA2ENST00000397806.1 linkuse as main transcriptc.-24G>T 5_prime_UTR_variant 1/32
HBA2ENST00000484216.1 linkuse as main transcript upstream_gene_variant 1

Frequencies

GnomAD3 genomes
Cov.:
1
GnomAD4 exome
Cov.:
0
GnomAD4 genome
Cov.:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesFeb 20, 2019The HBA2: c.24G>T; p.Lys8Asn variant (also known as Lys7Asn when numbered from the mature protein, rs281860604), to our knowledge, is not reported in the medical literature or gene-specific databases. However, a variant causing the same amino acid substitution (Hb Tatras: c.24G>C; p.Lys8Asn) is reported in the literature in an asymptomatic heterozygous individual with a normal hematological profile (Wajcman 1994, HbVar database). The c.24G>T variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The lysine at codon 8 is moderately conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious, although these predictions are low-confidence for the HBA2 gene. However, due to limited information, the clinical significance of the c.24G>T; p.Lys8Asn variant is uncertain at this time. References: HbVar link to HB Tatras: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=10 Wajcman H et al. Two new alpha chain variants found during glycated hemoglobin screening: Hb Tatras [alpha 7(A5)Lys-->Asn] and HB Lisbon [alpha 23(B4)Glu-->Asp]. Hemoglobin. 1994 Nov;18(6):427-32. -
alpha Thalassemia Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Feb 09, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.020
Cadd
Benign
22
Dann
Uncertain
0.99
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.28
FATHMM_MKL
Uncertain
0.94
D
M_CAP
Pathogenic
0.79
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Uncertain
0.56
D
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.86
D
PROVEAN
Uncertain
-3.9
D
REVEL
Uncertain
0.55
Sift
Uncertain
0.0050
D
Sift4G
Pathogenic
0.0010
D
Vest4
0.81
MutPred
0.97
Loss of methylation at K8 (P = 0.0143);
MVP
1.0
MPC
2.4
ClinPred
1.0
D
GERP RS
1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
gMVP
0.95

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs281860604; hg19: chr16-222935; API